All News

The product for the treatment of attention-deficit hyperactivity disorder (ADHD) needs no refrigeration or reconstitution at the pharmacy level.

New results published in CDC’s Morbidity and Mortality Weekly Report have identified a surge in pediatric acute lymphoblastic leukemia (ALL) during the period 2001 to 2008, followed by stabilization during 2008 to 2014.

In light of rising rates of preventive mastectomies among women with breast cancer, a new study looks at whether patient and surgeon factors, including attitudes toward breast conservation, affect the odds of receiving this surgery.

The HIV Medicine Association of the Infectious Disease Society of America recently published clinical practice guidelines for managing chronic pain in patients with HIV.

There is an association between asthma and the development of Crohn’s disease and with early and late-onset ulcerative colitis, according to a recent research.

Individuals with psoriasis face a greater risk of dying because of an alcohol-related death compared with people in the general population, according to recent research.

This week, the top stories in managed care included competing healthcare reform bills in the Senate; the FDA announced progress in clearing up the backlog of orphan drug requests; and a study examines how much it really costs to bring a drug to the market.

Paying close attention to the area around the wound and frequent measurement made a difference.

Cabazitaxel can now be used at a dose of 20 mg/m2 every 3 weeks in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have received a docetaxel-based treatment regimen.

Patients with relapsed follicular lymphoma now have a new treatment option: copanlisib, a kinase inhibitor that was recently approved through the FDA’s accelerated approval process.

In the wake of Hurricane Harvey, Houston is expected to face a host of health challenges, including air pollution. Here are 5 facts about how air pollution affects people’s health.

Researchers noted that the oral therapy functions independently of insulin to carry excess blood glucose out of the system.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The FDA has approved bevacizumab-awwb (Mvasi) as a treatment for multiple cancers. The drug has been approved as a biosimilar to its reference biologic, bevacizumab (Avastin), but it has not been approved as an interchangeable product.

After CMS and Novartis devised an outcomes-based payment approach for the new chimeric antigen receptor (CAR)-T treatment tisagenlecleucel (Kymriah), a group of representatives are requesting more information on the specifics of the agreement.

The results support policy positions that diabetes self-management education and support should occur at transitions in care.

Since primary care physicians spend more than half their workday on electronic health record (EHR) tasks, employing scribes to chart data could alleviate the burden on physicians and improve efficiency.

Psoriasis has a significant presence, affecting about 125 million people globally, but current estimates are fragmented because of a lack of a global standard. A new report suggested that global data will need a standardized approach of collection and analysis in order for more accurate estimates of psoriasis’ presence.

Just hours apart, 2 groups of senators unveiled health reform proposals that each take a drastically different approach to redefining the government’s role in healthcare.

The use of statin drugs in patients with chronic obstructive pulmonary disease is associated with benefits including decreased lung-related and all-cause mortality, according to a research.

The results were profound enough that researchers say it might be wise to screen patients for diabetes if their spouse is obese.

FDA Commissioner Scott Gottlieb, MD, announced the agency’s progress in streamlining the orphan drug review process and outlined plans to close a loophole currently hindering pediatric drug research.

Recent advances in brain imaging have improved understanding of acute and chronic pain, but have led to an increased in the demand to use this data for insurance and medical legal cases. However, a task force is advising against the use of brain imaging as a “lie detector” test for chronic pain.

The problem caused an overdelivery of insulin in some cases. A design update in April 2017 corrected the problem but some patients still have lots of defective infusion sets.

As the healthcare industry struggles to address rising costs and unaffordable care, attention is turning to value-based benefit design options. Altarum has released its outline for a new value-based insurance design model that it will test at pilot sites across the country.